NEOBASE® is a highly concentrated neomycin-based drug with bactericidal activity, highly effective against Gram-negative enterobacteria.
In addition to the high efficacy against enterobacteria, NEOBASE® shows the following features:
• Excellent solubility;
• Stability in water;
• High fluidity that assures a great miscibility with feed;
• Zero withdrawal period;
• Superior efficacy against unspecific enteritis.
FORMULA
Each 100 g of NEOBASE® contains:
Neomycin (as sulfate) ……………………….50.0 g
Excipients q.s………………………………….100.0 g
DIRECTIONS FOR USE
Poultry: The recommended dose for the control of enteric diseases in poultry is 20 mg of neomycin, which is equivalent to 40 mg of NEOBASE® per kilogram of body weight per day, for 5 to 7 consecutive days.
Swine: The recommended dose for the control of enteric diseases in swine is 10 to 20 mg of neomycin, which is equivalent to 20 to 40 mg of NEOBASE® per kilogram of body weight per day, for 7 consecutive days.
Presentation
200 g Sachet in box with 25 sachets;
20 kg Bag.
Withdrawal Period
A withdrawal period is not required before the slaughter of animals intended for human consumption.
